Cargando…
CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway
INTRODUCTION: Acute myeloid leukemia (AML), the hematological malignant tumor with high mortality, is still difficult to treat. CD40L is a type II transmembrane protein, which has been reported to have the potential to inhibit growth of some cancer cells. MATERIALS AND METHODS: In order to determine...
Autores principales: | Feng, Zhongxin, Chen, Qi, Ren, Mingqiang, Tian, Zuguo, Gong, Yuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476227/ https://www.ncbi.nlm.nih.gov/pubmed/31114244 http://dx.doi.org/10.2147/OTT.S175347 |
Ejemplares similares
-
CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway [Corrigendum]
por: Feng, Z, et al.
Publicado: (2019) -
Raised CD40L expression attenuates drug resistance in Adriamycin-resistant THP-1 cells
por: Feng, Zhongxin, et al.
Publicado: (2020) -
Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: TIAN, FENG, et al.
Publicado: (2015) -
Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: Tian, Feng, et al.
Publicado: (2023) -
Activation of CD147 with Cyclophilin A Induces the Expression of IFITM1 through ERK and PI3K in THP-1 Cells
por: Kim, Ju-Young, et al.
Publicado: (2010)